← SynDRA
VERALIPRIDE
SynDRA canonical compound SYN0031476 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | DRD2 |
|---|
| Mechanism of action | dopamine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- DRD2 ANTAGONIST
- Dopamine D2 receptor antagonist
- dopamine receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- DRD3
- CA12
- KCNH2
- DRD1
- CA9
- CA7
- CA6
- CA5B
- HTR1A
- CA4
- CA2
- CA14
- CA13
- CA5A
- CA1
- ADRA2C
- ADRA2B
- NR3C1
- HTR2B
- HTR2C
- HTR3A
- SLC6A4
- MAOA
- MC3R
- SLC6A3
- MLNR
- NPY1R
- NR1I2
- OPRD1
- PDE4D
- OPRK1
- OPRM1
- SLC6A2
- SLC47A2
- SLC47A1
- SLC29A1
- PDE3A
- PTGS2
- PGR
- HTR2A
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Antipsychotic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Psychotropic Drugs
- Tranquilizing Agents
ATC classes
Cross-references
Synonyms
- (+/-)-Veralipride
- Veraliprida
- Agradil
- Agreal
- Veralipridum
- S7064109UD
- DTXCID4026268
- RefChem:193953
- N05AL06
- Veralipride [INN]
- LIR-1660
- Veralipride-d6
- Veralipride (INN)
- NCGC00160642-01
- (+/-)-Veralipride;LIR166
- Veralipridum [INN-Latin]
- Veraliprida [INN-Spanish]
- Velaripride
- UNII-S7064109UD
- RYJXBGGBZJGVQF-UHFFFAOYSA-N
- EINECS 266-435-5
- Agreal (TN)
- MFCD00867658
- VERALIPRIDE [MI]
- ()-Veralipride;LIR166
- VERALIPRIDE [MART.]
- VERALIPRIDE [WHO-DD]
- SCHEMBL237519
- orb1299643
- SCHEMBL32682196
- CHEBI:135600
- N-((1-Allyl-2-pyrrolidinylmethyl)-5-sulfamoyl-2-veratramid
- FEA25880
- Tox21_111949
- AKOS025402237
- AC-6822
- CS-6854
- AS-74017
Look up VERALIPRIDE in the interactive SynDRA portal →